1. A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancer

   • Zoe Kemp
   • Alison Jones

   Review 08 August 2011 Pages: 603 - 614

2. The human papillomavirus (HPV) vaccine and cervical cancer: Uptake and next steps

   • Sherri N. Sheinfeld Gorin
   • Beth A. Glenn
   • Rebecca B. Perkins

   Review 01 August 2011 Pages: 615 - 639

3. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina

   • Peter Eizenberg
   • Robert Booy
   • Françoise Weber

   Original Research Open access 11 July 2011 Pages: 640 - 649

4. The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen

   • Christoph Kapitza
   • Milan Zdravkovic
   • Anne Flint

   Original Research 20 July 2011 Pages: 650 - 660

5. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%

   • Maria-Luise Scherzer
   • Ivana Liehneova
   • Dietmar Schnober

   Original Research Open access 15 July 2011 Pages: 661 - 670

6. Impact of infliximab adherence on Crohn’s disease-related healthcare utilization and inpatient costs

   • Chureen T. Carter
   • Heidi C. Waters
   • Daniel B. Smith

   Original Research 03 August 2011 Pages: 671 - 683

7. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel

   • Andrea Pession
   • Riccardo Masetti
   • Fabrizio Pane

   Original Research 15 July 2011 Pages: 684 - 697

8. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)

   • Yutaka Mori
   • Takaaki Tanaka
   • Kazunori Utsunomiya

   Original Research 06 July 2011 Pages: 698 - 706